BIO89-100 reduces liver fat, lowers triglycerides in adults with NASH – Healio
Frias JP, et al. BIO89-100 demonstrated robust reductions in liver fat and liver fat volume (LFV) by MRI-PDFF, favorable tolerability and potential for weekly (QW) or every 2 weeks (Q2W) dosing in a phase 1b/2a…